Paired-Pulse Inhibition in the Auditory Cortex in Parkinson's Disease and Its Dependence on Clinical Characteristics of the Patients

Table 1

Backgrounds of patients with Parkinson’s disease.

Total No of patients	58
Men	28
Women	30
Age, years (Mean±SE)	61.5±1.1(45–74)
Duration of illness, years (Mean±SE)	7.6±0.7(2–22)
Hoehn and Yahr stage; (No of cases)
Stage 1.5	4
Stage 2.0	25
Stage 2.5	14
Stage 3.0	15
UPDRS scores (Mean±SE)	58.6±2.2(29–94)
MMSE scores (Mean±SE)	27.9±0.3(24–30)
Levodopadosage^∗, mg/day (Mean±SE); 46 cases	359.2±23.3(187.5–700)

Numerals in the parentheses represent data range. ∗The Levodopa dosage in the table represents the dosage of Levodopa in Nacom (250 mg L-Dopa and 25 mg L-Carbidopa).